APMD Stock Chart & Stats
$27.37
$1.74(6.79%)
―
--
Day’s Range― - ―
52-Week Range$16.12 - $35.29
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
$1.17B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.12
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding41,623,184
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$45.50Price Target Upside― Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Apnimed, Inc. News
APMD FAQ
What was Apnimed, Inc.’s price range in the past 12 months?
Apnimed, Inc. lowest stock price was $16.12 and its highest was $35.29 in the past 12 months.
What is Apnimed, Inc.’s market cap?
Apnimed, Inc.’s market cap is $1.17B.
When is Apnimed, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Apnimed, Inc.’s earnings last quarter?
Currently, no data Available
Is Apnimed, Inc. overvalued?
According to Wall Street analysts Apnimed, Inc.’s price is currently Undervalued.
Does Apnimed, Inc. pay dividends?
Apnimed, Inc. does not currently pay dividends.
What is Apnimed, Inc.’s EPS estimate?
Apnimed, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Apnimed, Inc. have?
Apnimed, Inc. has 41,623,184 shares outstanding.
What happened to Apnimed, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Apnimed, Inc.?
Currently, no hedge funds are holding shares in APMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Apnimed, Inc. Stock Smart Score
Company Description
Apnimed, Inc.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.